IDT Biologika
IDT Biologika is a leading global CDMO providing end-to-end services in the development and manufacture of vaccines, gene & immune therapeutics, and sterile injectables. With over 100 years of expertise, the company supports pharmaceutical and biotech companies worldwide, focusing on innovation, quality, and sustainability. It has a strong history of research, development, and manufacturing, including experience with live viruses and biotherapeutics, and is committed to shaping a healthier world through reliable partnerships and advanced technologies. The company emphasizes collaboration and transparency with clients, aiming to improve processes through innovation and expertise. It has made significant investments in expanding its manufacturing capacity over the years, including installation of new assembly lines, filling lines, and GMP upgrades. IDT Biologika maintains rigorous compliance with regulatory standards, with regular inspections by agencies such as FDA, EMA, and ANVISA, demonstrating its commitment to quality and operational excellence.
Industries
Nr. of Employees
Very Large (1000+)
IDT Biologika
Dessau, Sachsen-Anhalt, Germany, Europe
Services
Aseptic filling of vials and pre-filled syringes with integrated lyophilization services covering small-scale clinical batches to high-throughput commercial production, including processing of viral products under appropriate biosafety controls.
End-to-end drug substance manufacturing using multiple upstream and downstream platforms for clinical and commercial supply, with process validation and facility capacity options.
Process development encompassing upstream/downstream optimization, formulation work, process characterization and technology transfer to manufacturing sites to support scale-up.
Analytical method development, implementation and validation, in-process testing, batch release testing and stability studies supported by LIMS and fast-track assay options.
Provision, qualification and generation of master and working cell banks to support upstream manufacturing and viral product production in accordance with regulatory expectations.
Regulatory guidance and audit hosting to support submissions and inspections; routine inspection activity includes regular official inspections and customer audits with experience interacting with major regulatory agencies.
Aseptic filling of vials and pre-filled syringes with integrated lyophilization services covering small-scale clinical batches to high-throughput commercial production, including processing of viral products under appropriate biosafety controls.
End-to-end drug substance manufacturing using multiple upstream and downstream platforms for clinical and commercial supply, with process validation and facility capacity options.
Process development encompassing upstream/downstream optimization, formulation work, process characterization and technology transfer to manufacturing sites to support scale-up.
Analytical method development, implementation and validation, in-process testing, batch release testing and stability studies supported by LIMS and fast-track assay options.
Provision, qualification and generation of master and working cell banks to support upstream manufacturing and viral product production in accordance with regulatory expectations.
Regulatory guidance and audit hosting to support submissions and inspections; routine inspection activity includes regular official inspections and customer audits with experience interacting with major regulatory agencies.
Expertise Areas
- Vaccine contract development and manufacturing
- Viral vector and viral product manufacturing
- Aseptic fill‑finish and lyophilized product manufacturing
- Upstream and downstream bioprocess development
Key Technologies
- GMP-compliant BSL-2 manufacturing practices
- Fixed-bed bioreactors
- Stirred-tank bioreactors
- Single-use systems
News & Updates
Meet Dr. Nanette Schlatermund and Min Young Kim at the event in Amsterdam, October 14-16, 2025.
Meet the IDT team at the event in Germany, October 28-30, 2025.
IDT Biologika was honored as a winner in the Biologics International category at the CDMO Leadership Awards 2025.
Meet Dr. Nanette Schlatermund and Min Young Kim at the event in Amsterdam, October 14-16, 2025.
Meet the IDT team at the event in Germany, October 28-30, 2025.
IDT Biologika was honored as a winner in the Biologics International category at the CDMO Leadership Awards 2025.